Related Experiment Video
Updated: Mar 13, 2026

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
Drug Information Association (DIA) - 52nd Annual Meeting (June 26-30, 2016 - Philadelphia, Pennsylvania, USA)
R Ballinger1, M Spence2, W Chalkley2
1Thomson Reuters, Rockville, Maryland USA. regina.ballinger@thomsonreuters.com.
Abstract:
The Drug Information Association's Annual Meeting is the largest global event which crosses all disciplines involved in the discovery development and life cycle management of healthcare products. The 2016 meeting, its 52nd occurrence, brought experts from regulatory and government agencies, industry, academia and health and patient organizations together to discuss novel therapies in development and how to use these to enhance health and well-being in patient groups, with the hope of increasing knowledge across all areas involved.
More Related Videos
Related Concept Videos
Therapeutic Drug Monitoring: Overview and Classification
Drug Products: Biologics, Biosimilars and Interchangeables
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Drug Dosing: Geriatric Patients
Clinically Relevant Drug Product Specifications: Methods of Establishment
Dosage Regimen: Individualization

